{
  "description": null,
  "compose": {
    "include": [ {
      "system": "http://www.icd10data.com/icd10pcs",
      "concept": [ {
        "code": "XW033H5",
        "display": "Introduction of Tocilizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5"
      }, {
        "code": "XW043H5",
        "display": "Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5"
      } ],
      "version": "2022"
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113883.3.3616.200.110.102.4019.json",
  "package_name": "us.nlm.vsac",
  "date": "2020-12-17T01:00:39-05:00",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2020-12-17T01:00:39.000-05:00"
  },
  "publisher": "Clinical Architecture",
  "name": "COVID19 ICD10PCS Value Set for Administration of Tocilizumab",
  "type": null,
  "experimental": null,
  "resourceType": "ValueSet",
  "title": null,
  "package_version": "0.6.0",
  "status": "active",
  "id": "4c7c6d41-0c55-4a32-b94f-6882088eca18",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.4019",
  "version": "20201217"
}